Nimish Patel, Pharm.D., M.S., AAHIVP

Bio: 

Education

Ph.D., Epidemiology (in-progress), SUNY School of Public Health, Albany, NY
M.S., Epidemiology, SUNY School of Public Health, Albany, NY
Infectious Diseases Outcomes Fellow, Department of Pharmacy Practice, Albany College of Pharmacy and Health Sciences, Albany, NY
HIV Specialty Pharmacy Resident, University Health Network – Toronto General Hospital, McGill University Health Centre – L’Institut Thoracique, Toronto, ONT
Pharm.D., Albany College of Pharmacy and Health Sciences, Albany, NY

Research Interests

Epidemiology & Clinical Outcomes Research
Study design and methods 
Infectious diseases 
Hospital-acquired infections
HIV/AIDS treatment outcomes & predictors of response
Hepatitis B vaccine response among special populations
Hepatitis C treatment outcomes and predictors of response

Honors and Achievements

Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Infectious Diseases Fellows Grant Program (2009).
Infectious Diseases Society of America, Fellows Travel Grant Recipient. Awarded to infectious diseases fellows in recognition of excellence in abstract submission to the IDSA Annual Meeting (2009).

Selected Publications

Patel N, Harrington S, Dihmess A, Woo B, Masoud R, Martis P, Fiorenza M, Graffunder E, Evans A, McNutt LA, Lodise TP. Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae. J Antimicrob Chemother. 2011 Jul;66(7):1600-8. Epub 2011 Apr 19.

Patel N, Pai MP, Rodvold KA, Lomaestro B, Drusano GL, Lodise TP. Vancomycin: We Can't Get There from Here. Clin Infect Dis. 2011 Apr;52(8):969-74.

Cardone KE, Lodise TP, Patel N, Hoy CD, Meola S, Manley HJ, Drusano GL, Grabe DW. Pharmacokinetics and Pharmacodynamics of Intravenous Daptomycin during Continuous Ambulatory Peritoneal Dialysis. Clin J Am Soc Nephrol. 2011 May;6(5):1081-8. Epub 2011 Mar 10.

Patel N, , Veve M, Miller CD. Predictors of Clinically Significant Drug-Drug Interactions among Patients Treated with Non-nucleoside Reverse Transcriptase inhibitor-, Protease Inhibitor-, and Raltegravir-based Antiretroviral Regimens. Ann Pharmacother. 2011 Mar;45(3):317-24. Epub 2011 Mar 8.

Patel N, Cardone K, Grabe DW, Meola S, Hoy C, Manley H, Drusano GL, Lodise TP. Use of Pharmacokinetic and Pharmacodynamic Principles to Determine Optimal Administration of Daptomycin in Patients Receiving Standardized Thrice Weekly Hemodialysis. Antimicrob Agents Chemother. 2011 Apr;55(4):1677-83. Epub 2011 Jan 31.

Patel N, Scheetz MH, Drusano GL, Lodise TP. Identification of Optimal Renal Dosage Adjustments for Traditional and Extended Infusion Piperacillin/Tazobactam Dosing Regimens in Hospitalized Patients. Antimicrob Agents Chemother. 2010 Jan;54(1):460-5. Epub 2009 Oct 26.

Patel N, Lubanski P, Ferro S, Bonafede M, Harrington S, Evans A, Stellrecht K, Lodise TP. Correlation Between Vancomycin MIC Values and the MIC Values of Other Gram-positive Agents Among Patients with MRSA Bloodstream Infections. Antimicrob Agents and Chemother. 2009 Dec;53(12):5141-4. Epub 2009 Oct 5.

Lodise TP, Patel N, Lomaestro BM, Rodvold KA, Drusano GL. Relationship between Initial Vancomycin Concentration-Time Profile and Nephrotoxicity among Hospitalized Patients. Clin Infect Dis. 2009 Aug 15;49(4):507-14.

Patel GP, Simon D, Scheetz M, Crank CW, Lodise T, Patel N. The Effect of Time to Antifungal Therapy on Mortality in Candidemia Associated Septic Shock Am J Ther. 2009 Nov-Dec;16(6):508-11.

Patel GW, Patel N, Lat A, Trombley KC, Enbawe S, Smith R, Lodise TP. Outcomes of Extended Infusion Piperacillin/Tazobactam for Documented Gram-negative Infections. Diag Microbio Infect Dis. 64 (2009) 236–240.

Assistant Professor
Department of Pharmacy Practice